Evidence map›Paper›PMID 21030958›Full record

ArticleNature protocols2010

Conditionally controlling nuclear trafficking in yeast by chemical-induced protein dimerization.

Tao Xu, Cole A Johnson, Jason E Gestwicki, Anuj Kumar

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. FKBP Ligands-Where We Are and Where to Go?Frontiers in pharmacology · 2018
    Review
  12. Article
  13. Go in! Go out! Inducible control of nuclear localization.Current opinion in chemical biology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tao XuDepartment of Molecular, Cellular and Developmental Biology, Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.
Cole A Johnson
Jason E Gestwicki
Anuj Kumar
University of Michigan–Ann Arbor · US

Funding

Synthetic Genetic Analysis of the RAM network in C. albicansR21AI084539 · NIAID · UNIVERSITY OF ROCHESTER · PI KRYSAN, DAMIAN J, KUMAR, ANUJ · 2009 to 2010
$423k
NIAID NIH HHS R21 AI084539
6 · The paper itself

Abstract

We present here a protocol to conditionally control the nuclear trafficking of target proteins in yeast. In this system, rapamycin is used to heterodimerize two chimeric proteins. One chimera consists of a FK506-binding protein (FKBP12) fused to a cellular 'address' (nuclear localization signal or nuclear export sequence). The second chimera consists of a target protein fused to a fluorescent protein and the FKBP12-rapamycin-binding (FRB) domain from FKBP-12-rapamycin associated protein 1 (FRAP1, also known as mTor). Rapamycin induces dimerization of the FKBP12- and FRB-containing chimeras; these interactions selectively place the target protein under control of the cell address, thereby directing the protein into or out of the nucleus. By chemical-induced dimerization, protein mislocalization is reversible and enables the identification of conditional loss-of-function and gain-of-function phenotypes, in contrast to other systems that require permanent modification of the targeted protein. Yeast strains for this analysis can be constructed in 1 week, and the technique allows protein mislocalization within 15 min after drug treatment.

Indexed as

Active Transport, Cell NucleusProtein TransportNuclear Localization SignalsProtein MultimerizationSaccharomyces cerevisiaeSirolimusTacrolimus Binding Protein 1ANuclear Localization SignalsSirolimusTacrolimus Binding Protein 1A

Identifiers

PMID21030958
PMCPMC4976631
OpenAlexW2072235464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.